Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10308 |
| Vaccine Name | MVA-mBN85B |
| Disease Name | Measles |
| Disease Classification | Exanthous |
| Virus Name | Morbillivirus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Phase 2 |
| Manufacturer | Bavarian Nordic |
| Year of Manufacturing | 2012 |
| Manufacturing Country | South Africa |
| Age | 6 months - 6 years |
| Dosage | 2 doses 4 weeks apart |
| Administration Route | Subcutaneous |
| Adjuvant | NA |
| Target Strain | Attenuated Modified Vaccinia Virus Ankara, strain encoding hemagglutinin protein, fusion protein and nucleoprotein of measles virus |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | Rouvax |
| PMID | NA |
| Clinical Trial ID | NCT00891007 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT00891007?recrs=abde&cond=measles+vaccines&phase=123&draw=2&rank=3 |
| Additional Links | NA |